Does Allergan's Saint Regis Mohawk Tribe transactional move "rip off consumers"? By Annsley Merelle Ward at Monday, September 18, 2017 America Invents Act AmeriKat generic drug applications inter partes review native american pharmaceutical industry Sovereign immunity US patent law +
Judge sounds alarm of weakened US patent system, while industry groups start amending Section 101 By Annsley Merelle Ward at Monday, May 22, 2017 AIPLA AmeriKat IPO patent eligibility patent eligible subject matter Section 101 US patent law US patent law reform +
Breaking News: PTAB declines Bass hedge fund IPR challenges in Ampyra dispute By Annsley Merelle Ward at Tuesday, August 25, 2015 AmeriKat hedge fund IPR Kyle bass patent validity PTAB US patent law USPTO +
Letter from AmeriKat: Spiderman's web ensnares the US Supreme Court in Kimble v Marvel By Annsley Merelle Ward at Tuesday, June 30, 2015 AmeriKat Brulotte patent duration patent licence US patent law US Supreme Court US Supreme Court decision +
AIPPI Congress Report 7: The one where the second medical use resolution is adopted By Annsley Merelle Ward at Saturday, September 20, 2014 AIPPI AIPPI Congress AmeriKat European patent law event report incentivization innovation Second medical use US patent law +
Chief Judge Rader leaves his US Patent Chiefdom behind following ethical breaches By Merpel at Monday, May 26, 2014 cafc DC politics Judge Randall Rader Merpel US patent law +
Fee-shifting back in the news with Federal Circuit's Kilopass decsion By Annsley Merelle Ward at Thursday, January 02, 2014 AmeriKat attorney fees cafc federal circuit US patent infringement US patent law US patent law reform us patent litigation +
Excluded Subject Matter American Style - Association of Molecular Pathology v Myriad (CAFC, 2011) By Matt at Wednesday, August 03, 2011 patent eligibility US patent law +
Letter from AmeriKat: America Invents Act Remix By Annsley Merelle Ward at Sunday, July 17, 2011 America Invents Act AmeriKat US patent law US patent reform USPTO +